UCB plans interim FASTRAX study findings on patient-initiated axSpA care at ACR 2026

By Public Technologies
  • UCB will present 18 accepted abstracts on rheumatic diseases at the American College of Rheumatology congress in 2026.
  • Interim FASTRAX findings will evaluate patient outcomes and experiences across standard care and patient-initiated follow-up for axial spondyloarthritis.
  • The digital platform lets clinically stable patients monitor symptoms at home and seek support when needed, aiming to improve service efficiency.
  • Research will also cover the first application of TRM-SLE, a lupus treatment-response measure designed to complement existing measures; further validation is needed.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. UCB SA published the original content used to generate this news brief on November 05, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.